Scienture’s Arbli is commercially available through wholesalers nationwide

Scienture (SCNX) announced that Arbli Oral Suspension, 10mg/mL, is commercially available through full-line wholesalers nationwide. This milestone establishes Arbli as the first and only FDA-approved ready-to-use liquid losartan formulation accessible through established pharmaceutical distribution channels across the United States.